A pivotal role of Krüppel-like factor 5 in regulation of cancer stem-like cells in hepatocellular carcinoma

Cancer Biology and Therapy

Volumn 16, Issue 10, 2015, Pages 1453-1461

  Maehara, Osamu ^a,b   Sato, Fumiyuki ^a   Natsuizaka, Mitsuteru ^a   Asano, Ayaka ^a,b   Kubota, Yoshimasa ^a   Itoh, Jun ^a   Tsunematsu, Seiji ^a   Terashita, Katsumi ^a   Tsukuda, Yoko ^a   Nakai, Masato ^a   Sho, Takuya ^a   Suda, Goki ^a   Morikawa, Kenichi ^a   Ogawa, Koji ^a   Chuma, Makoto ^c   Nakagawa, Koji ^b   Ohnishi, Shunsuke ^a   Komatsu, Yoshito ^a   Whelan, Kelly A ^d,e   Nakagawa, Hiroshi ^d,e   Takeda, Hiroshi ^b   Sakamoto, Naoya ^a   more..

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

acetylation; cancer stem cell; CD133; CD44; hepatocellular carcinoma; KLF5

Indexed keywords

CD133 ANTIGEN; CD44V ANTIGEN; KRUPPEL LIKE FACTOR 5; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1; KRUPPEL LIKE FACTOR;

ACETYLATION; ANGIOGENESIS; ANTITUMOR GENE; ARTICLE; CANCER STEM CELL; CELL CYCLE; COLONY FORMATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NEXT GENERATION SEQUENCING; PROTEIN EXPRESSION; REGULATORY MECHANISM; RNA SEQUENCE; UPREGULATION; WILD TYPE; GENETICS; LIVER TUMOR; PATHOLOGY; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIVER NEOPLASMS; NEOPLASTIC STEM CELLS;

EID: 84945437128     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.1080/15384047.2015.1070992     Document Type: Article

References (46)

1. J.Ferlay, H.R.Shin, F.Bray, D.Forman, C.Mathers, D.M.Parkin. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int JCancer J Int du Cancer 2010; 127:2893-917; PMID:21351269; http://dx.doi.org/10.1002/ijc.25516
2. M.Natsuizaka, T.Omura, T.Akaike, Y.Kuwata, K.Yamazaki, T.Sato, Y.Karino, J.Toyota, T.Suga, M.Asaka. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol 2005; 20:1781-7; PMID:16246200; http://dx.doi.org/10.1111/j.1440-1746.2005.03919.x
3. K.Uchino, R.Tateishi, S.Shiina, M.Kanda, R.Masuzaki, Y.Kondo, T.Goto, M.Omata, H.Yoshida, K.Koike. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer 2011; 117:4475-83; PMID:21437884; http://dx.doi.org/10.1002/cncr.25960
4. D.J.Yoo, K.M.Kim, Y.J.Jin, J.H.Shim, G.Y.Ko, H.K.Yoon, K.B.Sung, J.L.Lee, Y.K.Kang, Y.S.Lim, et al. Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients? J Gastroenterol Hepatol 2011; 26:145-54; PMID:21175808; http://dx.doi.org/10.1111/j.1440-1746.2010.06341.x
5. A.L.Cheng, Y.K.Kang, Z.Chen, C.J.Tsao, S.Qin, J.S.Kim, R.Luo, J.Feng, S.Ye, T.S.Yang, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009; 10:25-34; PMID:19095497; http://dx.doi.org/10.1016/S1470-2045(08)70285-7
6. J.M.Llovet, S.Ricci, V.Mazzaferro, P.Hilgard, E.Gane, J.F.Blanc, A.C.de Oliveira, A.Santoro, J.L.Raoul, A.Forner, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359:378-90; PMID:18650514; http://dx.doi.org/10.1056/NEJMoa0708857
7. H.Clevers. The cancer stem cell: premises, promises and challenges. Nat Med 2011; 17:313-9; PMID:21386835; http://dx.doi.org/10.1038/nm.2304
8. J.E.Visvader, G.J.Lindeman. Cancer stem cells: current status and evolving complexities. Cell Stem Cell 2012; 10:717-28; PMID:22704512; http://dx.doi.org/10.1016/j.stem.2012.05.007
9. S.Ma, K.W.Chan, L.Hu, T.K.Lee, J.Y.Wo, I.O.Ng, B.J.Zheng, X.Y.Guan. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007; 132:2542-56; PMID:17570225; http://dx.doi.org/10.1053/j.gastro.2007.04.025
10. Z.F.Yang, P.Ngai, D.W.Ho, W.C.Yu, M.N.Ng, C.K.Lau, M.L.Li, K.H.Tam, C.T.Lam, R.T.Poon, et al. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 2008; 47:919-28; PMID:18275073; http://dx.doi.org/10.1002/hep.22082
11. T.Yamashita, J.Ji, A.Budhu, M.Forgues, W.Yang, H.Y.Wang, H.Jia, Q.Ye, L.X.Qin, E.Wauthier, et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009; 136:1012-24; PMID:19150350; http://dx.doi.org/10.1053/j.gastro.2008.12.004
12. Z.Zhu, X.Hao, M.Yan, M.Yao, C.Ge, J.Gu, J.Li. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma. Int JCancer J Int du Cancer 2010; 126:2067-78; PMID:19711346; http://dx.doi.org/10.1002/ijc.24728
13. T.K.Lee, A.Castilho, V.C.Cheung, K.H.Tang, S.Ma, I.O.Ng. CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell 2011; 9:50-63; PMID:21726833; http://dx.doi.org/10.1016/j.stem.2011.06.005
14. X.R.Yang, Y.Xu, B.Yu, J.Zhou, S.J.Qiu, G.M.Shi, B.H.Zhang, W.Z.Wu, Y.H.Shi, B.Wu, et al. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Gut 2010; 59:953-62; PMID:20442200; http://dx.doi.org/10.1136/gut.2008.176271
15. Y.C.Ma, J.Y.Yang, L.N.Yan. Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis. Eur J Gastroenterol Hepatol 2013; 25:1007-16; PMID:23478672; http://dx.doi.org/10.1097/MEG.0b013e32836019d8
16. K.Schulze, C.Gasch, K.Staufer, B.Nashan, A.W.Lohse, K.Pantel, S.Riethdorf, H.Wege. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma. Int JCancer J Int du Cancer 2013; 133:2165-71; PMID:23616258; http://dx.doi.org/10.1002/ijc.28230
17. J.T.Dong, C.Chen. Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell Mol Life Sci 2009; 66:2691-706; PMID:19448973; http://dx.doi.org/10.1007/s00018-009-0045-z
18. A.Mori, C.Moser, S.A.Lang, C.Hackl, E.Gottfried, M.Kreutz, H.J.Schlitt, E.K.Geissler, O.Stoeltzing. Up-regulation of Kruppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alpha. Mol Cancer Res 2009; 7:1390-8; PMID:19671674; http://dx.doi.org/10.1158/1541-7786.MCR-08-0525
19. J.M.Noto, T.Khizanishvili, R.Chaturvedi, M.B.Piazuelo, J.Romero-Gallo, A.G.Delgado, S.S.Khurana, J.C.Sierra, U.S.Krishna, G.Suarez, et al. Helicobacter pylori promotes the expression of Kruppel-like factor 5, a mediator of carcinogenesis, in vitro and in vivo. PloS One 2013; 8:e54344
20. Y.Fujii, K.Yoshihashi, H.Suzuki, S.Tsutsumi, H.Mutoh, S.Maeda, Y.Yamagata, Y.Seto, H.Aburatani, M.Hatakeyama. CDX1 confers intestinal phenotype on gastric epithelial cells via induction of stemness-associated reprogramming factors SALL4 and KLF5. Proc Natl Acad Sci U S A 2012; 109:20584-9; PMID:23112162; http://dx.doi.org/10.1073/pnas.1208651109
21. Z.Dong, L.Yang, D.Lai. KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression. Cell Prolif 2013; 46:425-35; PMID:23869764; http://dx.doi.org/10.1111/cpr.12043
22. P.Guo, K.W.Zhao, X.Y.Dong, X.Sun, J.T.Dong. Acetylation of KLF5 alters the assembly of p15 transcription factors in transforming growth factor-beta-mediated induction in epithelial cells. J Biol Chem 2009; 284:18184-93; PMID:19419955; http://dx.doi.org/10.1074/jbc.M109.007096
23. X.Li, B.Zhang, Q.Wu, X.Ci, R.Zhao, Z.Zhang, S.Xia, D.Su, J.Chen, G.Ma, et al. Interruption of KLF5 acetylation converts its function from tumor suppressor to tumor promoter in prostate cancer cells. Int JCancer J Int du Cancer 2015; 136:536-46; PMID:24931571
24. T.Shibata, H.Aburatani. Exploration of liver cancer genomes. Nat Rev Gastroenterol Hepatol 2014; 11:340-9; PMID:24473361; http://dx.doi.org/10.1038/nrgastro.2014.6
25. K.N.Nejak-Bowen, M.D.Thompson, S.Singh, W.C.Bowen, Jr., M.J.Dar, J.Khillan, C.Dai, S.P.Monga. Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin. Hepatology 2010; 51:1603-13; PMID:20432254; http://dx.doi.org/10.1002/hep.23538
26. H.Akita, J.U.Marquardt, M.E.Durkin, M.Kitade, D.Seo, E.A.Conner, J.B.Andersen, V.M.Factor, S.S.Thorgeirsson. MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism. Cancer Res 2014; 74:5903-13; PMID:25189530; http://dx.doi.org/10.1158/0008-5472.CAN-14-0527
27. T.Yamashita, A.Budhu, M.Forgues, X.W.Wang. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Cancer Res 2007; 67:10831-9; PMID:18006828; http://dx.doi.org/10.1158/0008-5472.CAN-07-0908
28. N.Oishi, T.Yamashita, S.Kaneko. Molecular biology of liver cancer stem cells. Liver Cancer 2014; 3:71-84; PMID:24944998; http://dx.doi.org/10.1159/000343863
29. B.B.McConnell, S.S.Kim, K.Yu, A.M.Ghaleb, N.Takeda, I.Manabe, A.Nusrat, R.Nagai, V.W.Yang. Kruppel-like factor 5 is important for maintenance of crypt architecture and barrier function in mouse intestine. Gastroenterology 2011; 141:1302-13, 13 e1-6
30. S.Wan, E.Zhao, I.Kryczek, L.Vatan, A.Sadovskaya, G.Ludema, D.M.Simeone, W.Zou, T.H.Welling. Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology 2014; 147:1393-404; PMID:25181692; http://dx.doi.org/10.1053/j.gastro.2014.08.039
31. K.H.Tang, S.Ma, T.K.Lee, Y.P.Chan, P.S.Kwan, C.M.Tong, I.O.Ng, K.Man, K.F.To, P.B.Lai, et al. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling. Hepatology 2012; 55:807-20; PMID:21994122; http://dx.doi.org/10.1002/hep.24739
32. T.Nakaya, S.Ogawa, I.Manabe, M.Tanaka, M.Sanada, T.Sato, M.M.Taketo, K.Nakao, H.Clevers, M.Fukayama, et al. KLF5 regulates the integrity and oncogenicity of intestinal stem cells. Cancer Res 2014; 74:2882-91; PMID:24626089; http://dx.doi.org/10.1158/0008-5472.CAN-13-2574
33. A.Pagliuca, C.Valvo, E.Fabrizi, S.di Martino, M.Biffoni, D.Runci, S.Forte, R.De Maria, L.Ricci-Vitiani. Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene 2013; 32:4806-13; PMID:23128394; http://dx.doi.org/10.1038/onc.2012.495
34. T.Ishimoto, O.Nagano, T.Yae, M.Tamada, T.Motohara, H.Oshima, M.Oshima, T.Ikeda, R.Asaba, H.Yagi, et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(−) and thereby promotes tumor growth. Cancer Cell 2011; 19:387-400; PMID:21397861; http://dx.doi.org/10.1016/j.ccr.2011.01.038
35. O.Nagano, S.Okazaki, H.Saya. Redox regulation in stem-like cancer cells by CD44 variant isoforms. Oncogene 2013; 32:5191-8; PMID:23334333; http://dx.doi.org/10.1038/onc.2012.638
36. S.M.Smith, Y.L.Lyu, L.Cai. NF-kappaB affects proliferation and invasiveness of breast cancer cells by regulating CD44 expression. PloS one 2014; 9:e106966; PMID:25184276; http://dx.doi.org/10.1371/journal.pone.0106966
37. S.Chanchevalap, M.O.Nandan, B.B.McConnell, L.Charrier, D.Merlin, J.P.Katz, V.W.Yang. Kruppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cells. Nucleic Acids Res 2006; 34:1216-23; PMID:16500892; http://dx.doi.org/10.1093/nar/gkl014
38. Z.Zhang, C.T.Teng. Phosphorylation of Kruppel-like factor 5 (KLF5/IKLF) at the CBP interaction region enhances its transactivation function. Nucleic Acids Res 2003; 31:2196-208; PMID:12682370; http://dx.doi.org/10.1093/nar/gkg310
39. C.Chen, X.Sun, P.Guo, X.Y.Dong, P.Sethi, X.Cheng, J.Zhou, J.Ling, J.W.Simons, J.B.Lingrel, et al. Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells. J Biol Chem 2005; 280:41553-61; PMID:16223724; http://dx.doi.org/10.1074/jbc.M506183200
40. Y.Luan, P.Wang. FBW7-mediated ubiquitination and degradation of KLF5. World J Biol Chem 2014; 5:216-23; PMID:24921010
41. J.X.Du, A.B.Bialkowska, B.B.McConnell, V.W.Yang. SUMOylation regulates nuclear localization of Kruppel-like factor 5. J Biol Chem 2008; 283:31991-2002; PMID:18782761; http://dx.doi.org/10.1074/jbc.M803612200
42. S.Ohnishi, S.Ohnami, F.Laub, K.Aoki, K.Suzuki, Y.Kanai, K.Haga, M.Asaka, F.Ramirez, T.Yoshida. Downregulation and growth inhibitory effect of epithelial-type Kruppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem Biophy Res Commun 2003; 308:251-6; PMID:12901861; http://dx.doi.org/10.1016/S0006-291X(03)01356-1
43. M.Natsuizaka, S.Ohashi, G.S.Wong, A.Ahmadi, R.A.Kalman, D.Budo, A.J.Klein-Szanto, M.Herlyn, J.A.Diehl, H.Nakagawa. Insulin-like growth factor-binding protein-3 promotes transforming growth factor-{beta}1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells. Carcinogenesis 2010; 31:1344-53; PMID:20513670; http://dx.doi.org/10.1093/carcin/bgq108
44. S.Ohashi, M.Natsuizaka, Y.Yashiro-Ohtani, R.A.Kalman, M.Nakagawa, L.Wu, A.J.Klein-Szanto, M.Herlyn, J.A.Diehl, J.P.Katz, et al. NOTCH1 and NOTCH3 coordinate esophageal squamous differentiation through a CSL-dependent transcriptional network. Gastroenterology 2010; 139:2113-23; PMID:20801121; http://dx.doi.org/10.1053/j.gastro.2010.08.040
45. S.Ohashi, M.Natsuizaka, S.Naganuma, S.Kagawa, S.Kimura, H.Itoh, R.A.Kalman, M.Nakagawa, D.S.Darling, D.Basu, et al. A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. Cancer Res 2011; 71:6836-47; PMID:21890822; http://dx.doi.org/10.1158/0008-5472.CAN-11-0846
46. A.Mortazavi, B.A.Williams, K.McCue, L.Schaeffer, B.Wold. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008; 5:621-8; PMID:18516045; http://dx.doi.org/10.1038/nmeth.1226